SINOPHARM TECH (08156.HK): Public Float Restored to 25.01% After INED Sale
NewTimeSpace News: On 5 October 2026, Sinopharm Tech Holdings Limited (stock code: 08156) announced that, as informed by Mr. Heung Pik Lun, an independent non-executive Director, and based on the disclosure of interest form filed by him, following an on-exchange disposal of an aggregate of 380,000 ordinary shares of the Company on 5 October 2026, the public float of the Company has become approximately 25.01%, which fulfils the minimum public float requirement of 25.0% prescribed under Rule 17.37B(1) of the GEM Listing Rules.
The announcement showed that the Company had previously issued an announcement dated 16 September 2026 in relation to the public float shortfall. As at the date of the announcement, the Company had 633,693,055 ordinary shares in issue; Integrated Asset Management (Asia) Limited held 321,694,520 shares (approximately 50.76%), Quantum Worldwide Investments Limited held 150,000,000 shares (approximately 23.67%), Mr. Heung Pik Lun held 3,540,000 shares (approximately 0.56%) and public shareholders held 158,458,535 shares (approximately 25.01%).
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- METIS TECHBIO-P(07666.HK) closed 12.7% higher, the Hang Seng Pharmaceuticals & Biotechnology Sector saw divergent trends
- MINIMAX-W(00100.HK) closed 7.06% higher, the Hang Seng Software & Services Sector saw divergent trends
- KNOWLEDGE ATLAS(02513.HK) closed 19.29% lower, closing at HKD 1640
- LAIFUAL(03952.HK) closed 44.95% higher, closing at HKD 94
- HJ SCIENCE-B(06132.HK) closed 15.38% higher, the Hang Seng Pharmaceuticals & Biotechnology Sector saw divergent trends